• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Provectus Biopharmaceuticals Inc

+ Add to Watchlist

PVCT:US

2.1000 USD 0.0500 2.33%

As of 15:55:55 ET on 04/16/2014.

Snapshot for Provectus Biopharmaceuticals Inc (PVCT)

Open: 2.0700 Day's Range: 2.0400 - 2.1900 Volume: 409,034
Previous Close: 2.1500 52wk Range: 0.5800 - 6.0300 1-Yr Rtn: +195.10%

Stock Chart for PVCT

No chart data available.
  • PVCT:US 2.1000
  • 1D
  • 1M
  • 1Y
2.1500
Interactive PVCT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PVCT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2000
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 363.87
Shares Outstanding (M) 172.45
30 Day Average Volume 798,411
Price/Book (mrq) 33.8718
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PVCT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PVCT

Provectus Biopharmaceuticals, Inc. researches and develops pharmaceutical products and therapies. The Company develops therapies designed to target and destroy melanoma, liver and breast cancer as well as treat psoriasis and atopic dermatitis.

H Craig DeesChairman/CEOTimothy C ScottPresident
Peter R CulpepperCFO/COO/SecretaryEric A WachterChief Technology Officer
More Company Profile & Key Executives for PVCT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil